Activist investor Parvus Asset Management builds stake in Novo Nordisk, stock climbs over 5%

From Yahoo Finance: 2025-06-10 11:10:00

Novo Nordisk’s U.S.-listed shares are down nearly 8% this year, facing slowing sales growth and competition from more effective weight loss drugs. An activist investor, Parvus Asset Management, is reportedly building a stake in the Danish drugmaker to influence the hiring of its next CEO. Novo Nordisk’s stock rose after this news, with American depositary shares up over 5% in Tuesday morning trading. CEO Lars Fruergaard Jørgensen will step away once a successor is found.



Read more at Yahoo Finance: Novo Nordisk Stock Climbs on Report of Activist Investor Parvus Building Stake